言語を選択
新規登録
お気に入りに追加

PE-Labeled Monoclonal Anti-Human CD5 Antibody, Mouse IgG1 (2C8A7) (0.03% Proclin)

COADS MS
DS

ユーザーレビュー
製品番号/仕様
価格
数量
FABm032-01-50tests
$200.00
FABm032-01-200tests (50tests X 4)
$720.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0
推奨新製品
関連アイテム

製品詳細

  • Source

    Monoclonal Anti-Human CD5 Antibody, Mouse IgG1 (2C8A7) is a mouse monoclonal antibody produced from hybridoma.

  • Clone

    2C8A7

  • Isotype

    Mouse IgG1, Kappa

  • Host Species

    Mouse

  • Reactivity

    Human

  • Immunogen

    Purified Human CD5 Protein

  • Conjugate

    PE

    Excitation Wavelength: 488 nm / 561 nm

    Emission Wavelength: 575 nm

  • Specificity

    This product is a specific antibody specifically reacts with CD5 protein.

  • Application

    Flow Cytometry (Evaluation of the expression of CD5 on Human cells).

  • Recommended Dilution

    1:20

  • Isotype Control

    The isotype control is sold separately; please refer to Cat. No. DNP-PM1 for product information.

  • Form

    Liquid

  • Formulation

    Supplied as 0.2 μm-filtered solution in PBS (pH 7.4) containing 0.03% ProClin 300 and 0.2% BSA, with trehalose as protectant.

    Please contact us for customized product forms or formulations.

  • Shipping

    Liquid product is shipped at blue ice.

  • Storage

    Please protect from light and avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. Store at 2-8 °C for 12 months.

  • Notices

    Product Specific Notices: For research use only.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • Bioactivity-FACS

    CD5 FACS

    Flow cytometric analysis of Jurkat staining with Anti-Human CD5 Antibody, Mouse IgG1 (2C8A7) (Cat. No. FABm032-01) FACS Protocol at 1:20 dilution (5 μL of the antibody stock solution corresponds to labeling of 1e6 cells in a final volume of 100 µL), compared with isotype control antibody. PE signal was used to evaluate the binding activity (QC tested).

    Protocol

ユーザーレビュー
コメントを投稿

バックグランド

T-cell surface glycoprotein CD5 is also known as Lymphocyte antigen T1/Leu-1 and LEU1,which is phosphorylated on tyrosine residues by LYN,so CD5 can create binding sites for PTPN6/SHP-1.CD5 may act as a receptor in regulating T-cell proliferation. CD5 is expressed at various developmental and activation stages on human B cells.CD5 is a well established negative regulator of TCR and BCR signalling.CD5-positive cells may also prevent the emergence of autoimmunity by provision of cytokines such as IL-10. Development,selection and function of different B- and T-cell subsets or their preferential survival may be directly or indirectly dependent on different glycan structures associated with CD5 or CD5-like molecules.

最新の進展

 
医薬品開発の進捗
  • 英語名：

    T-cell surface glycoprotein CD5

  • カテゴリ：

  • 市販の医薬品数：

    0 詳細

  • 治験医薬品数：

    13 詳細

  • 最新の開発ステージ：

    Phase 2 Clinical

お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
  • 背景
共有：

採用情報法的規制サイトマッププライバシーポリシー利用規約
ウェブサイトに関するフィードバック
お問い合わせ

お問い合わせ
グローバル：+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8